Vaccine Development

Proving a Robust and Accelerated Human Vaccine Platform Provided the Foundation for a Uniquely Capable Biologics CDMO

Laura Ferrer, Ph.D.

HIPRA Biotech Services

mRNA Vaccine

When Review Stops at the Door: The FDA, mRNA Influenza Vaccines, and the Future of Regulatory Consistency

David Alvaro, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

Vaccines and the FDA

Guardrails for Vaccine Innovation Are Under Threat

David Alvaro, Ph.D.; Sophie Lutter, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

Vaccines and Autism

CDC Rewrites its Vaccine–Autism Guidance, Contradicting Decades of Science

David Alvaro, Ph.D.

Pharma's Almanac

Measles Outbreaks

The 2025 Measles Crisis and the Fight for Public Health Trust

David Alvaro, Ph.D.

Pharma's Almanac

Biologics

HIPRA Biotech Services' End-to-End Biologics Offering

HIPRA Biotech Services

Exosomes

Nature’s Nanocarriers: The Evolving Role of Exosomes in Targeted Drug Delivery

David Alvaro, Ph.D.

Pharma's Almanac

Oncology

From Coley’s Toxins to mRNA: Reflecting on the History of Cancer Vaccines

David Alvaro, Ph.D.

Pharma's Almanac

dbDNA

Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA

Jill Makin

Touchlight

Vaccines

Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines

David Dodd; Mark Newman, Ph.D.

GeoVax Inc.

Inhalation Vaccines

The Exciting Potential of Inhalation Vaccines

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Intranasal Vaccines

Increasing Safety, Efficacy, and Global Equity with Intranasal Vaccines

Chad Costley, M.D.

BlueWillow Biologics

Vaccine and Cell & Gene Therapies

Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics

Ulrike Fiedler Dr. Rer. Nat.

IDT Biologika

Animal Vaccines

World-Class Solutions for Livestock Vaccines

Medgene Labs

Vaccines

100 Years in Vaccines and Looking Toward the Future

IDT Biologika